A detailed history of Concurrent Investment Advisors, LLC transactions in Haleon PLC stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 12,680 shares of HLN stock, worth $121,094. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,680
Previous 16,906 25.0%
Holding current value
$121,094
Previous $140 Million 3.93%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$8.32 - $10.7 $35,160 - $45,218
-4,226 Reduced 25.0%
12,680 $134 Million
Q2 2024

Jul 30, 2024

BUY
$8.01 - $8.64 $13,096 - $14,126
1,635 Added 10.71%
16,906 $140 Million
Q1 2024

May 07, 2024

BUY
$8.02 - $8.67 $3,224 - $3,485
402 Added 2.7%
15,271 $130 Million
Q4 2023

Apr 15, 2024

BUY
$7.78 - $8.62 $115,680 - $128,170
14,869 New
14,869 $122 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.1B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Concurrent Investment Advisors, LLC Portfolio

Follow Concurrent Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concurrent Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concurrent Investment Advisors, LLC with notifications on news.